Weston family and Fairfax agree to buy UK drugstore chain Boots in US$8.9B deal

The Weston family, which controls Loblaw and Shoppers Drug Mart, is buying one of Britain's best-known retailers. Wittington Investments, the family's private holding company, said on Wednesday it has agreed to acquire the Boots pharmacy and beauty chain from private equity firm Sycamore Partners and the Pessina family in a deal valued at about US$8.9 billion including assumed debt, or roughly $12.7 billion Canadian, according to The Canadian Press.

Toronto-based Fairfax Financial Holdings is a partner. It has agreed to provide up to about US$2.3 billion toward the purchase price and is expected to own 50% of Boots after closing, while Wittington keeps operational control.

The deal at a glance

Galen Weston, chairman of Wittington, will become chairman of Boots.

• Price: about US$8.9 billion including debt (reported in the U.K. as £6.7 billion)
• Buyers: Wittington Investments (operational control) and Fairfax Financial (up to US$2.3 billion, 50% equity stake)
• Included: Boots' U.K. and Ireland retail and pharmacy business, Boots Opticians, No7 Beauty Company, and its Thailand and franchise operations
• Excluded: Mexico's Farmacias Benavides and Germany's Alliance Healthcare Deutschland, which stay with the sellers
• Scale: more than 1,800 stores and over 50,000 employees
• Expected closing: first quarter of 2027, subject to regulatory approval

Why the Westons want it

Weston described Boots as “one of Britain's most enduring businesses, with a rich heritage, a trusted name,” and said the new owners see a chance to improve it through “stable long-term ownership, further capital investment, and the renewed operating focus required to serve customers.” Plans include store upgrades, a better online experience and expanded health-care services.

The family knows the format. Loblaw, with more than 2,800 locations, bought Shoppers Drug Mart in 2014; Shoppers now has about 1,350 stores in Canada. Boots, founded as an herbalist in 1849, had passed through several owners, most recently Sycamore, which took Walgreens Boots Alliance private for US$10 billion in March 2025.

What it means for listed shareholders

Because Wittington is privately held, the purchase does not sit inside Loblaw or George Weston Ltd. RBC analyst Irene Nattel said the deal would have little impact on either company. GlobalData's Neil Saunders said he expects better stores, e-commerce and growth at No7 over time, adding that Wittington's ownership “understands retail.”

For Fairfax, primarily a property and casualty insurer and reinsurer, the deal is a large equity bet on a consumer business outside its core insurance operations.

The risks

Boots operates in a tough U.K. high-street retail market and has changed hands repeatedly. The deal still needs regulatory approval, and turnaround plans of this size usually take years to show results. Fairfax has not disclosed how it will fund its commitment.

What it means for you

Nothing changes for Canadian shoppers at Shoppers Drug Mart or Loblaw stores. For investors, the main takeaway is that a big headline deal by a controlling family does not automatically affect the listed companies it controls. If you own Loblaw, George Weston or Fairfax shares directly or through a TSX index fund, check how the companies themselves describe their exposure before reacting. This article is general information, not personal financial advice.

Related

• Best Canadian retail stocks
• Best Canadian insurance stocks

More in Companies

• Ottawa and Ontario unveil $8.7-billion plan to shield steel, auto and mining from U.S. tariffs
• Aritzia's revenue jumps 44% to $1.17B as U.S. sales surge 60%
• CRTC clears Corus recapitalization, handing lenders 99% of the broadcaster
• Sobeys owner Empire lifts Q1 profit, says it won't accept tariff-related price hikes from suppliers